Wolfson Group, a Scotland-based international consumer wellness company, has announced that three of its flagship brands—PhenQ, TestoPrime, and YourBiology—will soon be available on OneLavi.com. This move marks a significant step in the company's strategy to expand its U.S. distribution beyond Amazon, where these brands have already established a strong presence. The upcoming availability on OneLavi provides another online destination for U.S. consumers to discover and purchase Wolfson Group products, supporting the company's broader effort to build a diversified retail and e-commerce footprint in the United States.
The expansion is important because it reflects a growing trend among wellness companies to reduce reliance on a single marketplace. By adding OneLavi as a retail partner, Wolfson Group is not only increasing accessibility for consumers but also strengthening its resilience in the competitive U.S. wellness market. The three brands represent distinct areas: PhenQ focuses on weight management, TestoPrime serves the men's wellbeing category, and YourBiology targets women's gut health and everyday wellness. This multi-category approach allows Wolfson Group to cater to a wide range of consumer needs and preferences.
The founder and CEO of Wolfson Group commented, "Expanding onto OneLavi is another important step in making our brands more accessible to consumers across the U.S. Amazon has provided us with a strong foundation in the market, and we're now building on that presence by developing additional channels for our portfolio." This sentiment underscores the company's commitment to a multi-channel strategy that includes both online and brick-and-mortar retail.
The OneLavi launch follows a series of U.S. initiatives by Wolfson Group. In September, the company participated in the ECRM Vitamin, Weight Management & Sports Nutrition Session in Palm Beach Gardens, Florida, where it introduced its portfolio during scheduled retail meetings. These efforts demonstrate Wolfson Group's proactive approach to expanding its American presence and building relationships with retailers.
Wolfson Group has also been examining how consumer wellness interests increasingly extend across multiple categories, including weight management, cognitive wellness, gut health, men's and women's wellbeing, and healthy ageing. The company believes its diversified portfolio provides opportunities to serve consumers with different wellness priorities throughout various stages of life. By adding OneLavi to its U.S. distribution strategy, Wolfson Group is building multiple paths to the consumer rather than relying on a single marketplace or retail channel.
"Our U.S. strategy is about creating a broader and more sustainable distribution footprint over time," the founder added. "Adding new online retail relationships complements what we've already built and gives us another foundation as we continue exploring opportunities across both e-commerce and brick-and-mortar retail." This approach is likely to resonate with consumers who seek convenient access to trusted wellness brands across various platforms.
The implications of this announcement extend beyond mere distribution. For U.S. consumers, it means greater choice and easier access to Wolfson Group's science-led brands. For the company, it represents a strategic diversification that could mitigate risks associated with dependence on a single retailer and enhance its competitive position. As Wolfson Group continues to pursue additional U.S. distribution opportunities and invest in consumer education and brand development, its move onto OneLavi could serve as a model for other international wellness companies seeking to expand in the U.S. market.
